Literature DB >> 15525649

Angiotensin II and epidermal growth factor induce cyclooxygenase-2 expression in intestinal epithelial cells through small GTPases using distinct signaling pathways.

Lee W Slice1, Terence Chiu, Enrique Rozengurt.   

Abstract

Colorectal carcinogenesis is a multistep process involving genetic mutations and alterations in rigorously controlled signaling pathways and gene expression that control intestinal epithelial cell proliferation, differentiation, and apoptosis. Cyclooxygenase-2 (COX-2) is aberrantly expressed in premalignant adenomatous polyps and colorectal carcinomas and is associated with increased epithelial cell proliferation, decreased apoptosis, and increased cell invasiveness. Currently, knowledge of the regulation of expression of COX-2 by endogenous cell-surface receptors is inadequate. Recently, in a non-transformed rat intestinal epithelial cell line (IEC-18), we showed induction of cell proliferation and DNA synthesis by angiotensin II (Ang II) via the endogenous Ang II type 1 receptor (Chiu, T., Santiskulvong, C., and Rozengurt, E. (2003) Am. J. Physiol. 285, G1-G11). We report that Ang II potently stimulated expression of COX-2 mRNA and protein as an immediate-early gene response through the Ang II type 1 receptor, correlating with an increase in prostaglandin I2 production. Ang II induced Cdc42 activation and filopodial formation. COX-2 expression was induced by epidermal growth factor (EGF), which activated Rac with lamellipodial formation. Inhibition of small GTPases by Clostridium difficile toxin B blocked COX-2 expression by Ang II and EGF. Inhibition of ERK activation by U0126 or PD98059 significantly decreased EGF-dependent COX-2 expression, but did not affect Ang II-dependent COX-2 expression. Conversely, inhibition of p38MAPK by SB202190 or PD169316 inhibited COX-2 expression by Ang II, but did not block COX-2 induction by EGF. Ang II caused Ca2+ mobilization. Inhibition of Ca2+ signaling by 2-aminobiphenyl borate blocked Ang II-dependent COX-2 expression. EGF did not induce Ca2+ mobilization, and 2-aminobiphenyl borate did not inhibit EGF-dependent COX-2 expression. Inhibition of COX-2 expression correlated with inhibition of prostaglandin I2 production. Luciferase promoter assays showed that Ang II-dependent transcriptional activation of the COX-2 promoter was dependent on activation of small GTPases and p38(MAPK) and on Ca2+ signaling via the cAMP-responsive element/activating transcription factor cis-acting element.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15525649     DOI: 10.1074/jbc.M408172200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Rapid protein kinase D1 signaling promotes migration of intestinal epithelial cells.

Authors:  Steven H Young; Nora Rozengurt; James Sinnett-Smith; Enrique Rozengurt
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-05-17       Impact factor: 4.052

2.  Protein kinase D1 (PKD1) phosphorylation on Ser203 by type I p21-activated kinase (PAK) regulates PKD1 localization.

Authors:  Jen-Kuan Chang; Yang Ni; Liang Han; James Sinnett-Smith; Rodrigo Jacamo; Osvaldo Rey; Steven H Young; Enrique Rozengurt
Journal:  J Biol Chem       Date:  2017-04-13       Impact factor: 5.157

3.  Angiotensin II inhibits P-glycoprotein in intestinal epithelial cells.

Authors:  Anoop Kumar; Shubha Priyamvada; Vikas Soni; Arivarasu N Anbazhagan; Tarunmeet Gujral; Ravinder K Gill; Waddah A Alrefai; Pradeep K Dudeja; Seema Saksena
Journal:  Acta Physiol (Oxf)       Date:  2019-07-01       Impact factor: 6.311

4.  The synergistic induction of cyclooxygenase-2 in lung fibroblasts by angiotensin II and pro-inflammatory cytokines.

Authors:  Takaya Matsuzuka; Kathryn Miller; Lara Pickel; Chiyo Doi; Rie Ayuzawa; Masaaki Tamura
Journal:  Mol Cell Biochem       Date:  2008-10-01       Impact factor: 3.396

5.  Positive cross talk between protein kinase D and β-catenin in intestinal epithelial cells: impact on β-catenin nuclear localization and phosphorylation at Ser552.

Authors:  Jia Wang; Liang Han; James Sinnett-Smith; Li-Li Han; Jan V Stevens; Nora Rozengurt; Steven H Young; Enrique Rozengurt
Journal:  Am J Physiol Cell Physiol       Date:  2016-01-06       Impact factor: 4.249

6.  Biphasic Regulation of Yes-associated Protein (YAP) Cellular Localization, Phosphorylation, and Activity by G Protein-coupled Receptor Agonists in Intestinal Epithelial Cells: A NOVEL ROLE FOR PROTEIN KINASE D (PKD).

Authors:  Jia Wang; James Sinnett-Smith; Jan V Stevens; Steven H Young; Enrique Rozengurt
Journal:  J Biol Chem       Date:  2016-07-01       Impact factor: 5.157

7.  Helicobacter pylori VacA enhances prostaglandin E2 production through induction of cyclooxygenase 2 expression via a p38 mitogen-activated protein kinase/activating transcription factor 2 cascade in AZ-521 cells.

Authors:  Junzo Hisatsune; Eiki Yamasaki; Masaaki Nakayama; Daisuke Shirasaka; Hisao Kurazono; Yohtaro Katagata; Hiroyasu Inoue; Jiahuai Han; Jan Sap; Kinnosuke Yahiro; Joel Moss; Toshiya Hirayama
Journal:  Infect Immun       Date:  2007-06-25       Impact factor: 3.441

8.  Angiotensin II bi-directionally regulates cyclooxygenase-2 expression in intestinal epithelial cells.

Authors:  Tatsuo Tani; Rie Ayuzawa; Tetsuo Takagi; Tsutomu Kanehira; Dharmendra Kumar Maurya; Masaaki Tamura
Journal:  Mol Cell Biochem       Date:  2008-06-10       Impact factor: 3.396

9.  Loss of 15-hydroxyprostaglandin dehydrogenase increases prostaglandin E2 in pancreatic tumors.

Authors:  Hung Pham; Monica Chen; Aihua Li; Jonathan King; Eliane Angst; David W Dawson; Jenny Park; Howard A Reber; O Joe Hines; Guido Eibl
Journal:  Pancreas       Date:  2010-04       Impact factor: 3.327

10.  Epidermal growth factor increases prostaglandin E2 production via ERK1/2 MAPK and NF-kappaB pathway in fibroblast like synoviocytes from patients with rheumatoid arthritis.

Authors:  Seong-Su Nah; Hye-Jin Won; Eunyoung Ha; Insug Kang; Hong Yon Cho; Sook-Jin Hur; Sang-Hoon Lee; Hyung Hwan Baik
Journal:  Rheumatol Int       Date:  2009-08-13       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.